Similar articles

• Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?

  Strada SJ, Thompson WJ. Strada SJ, et al. Adv Cyclic Nucleotide Res. 1978;9:265-83. Adv Cyclic Nucleotide Res. 1978. PMID: 208379 Review. No abstract available.
• Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.

  Kang ES. Kang ES. Pediatr Res. 1978 Jul;12(7):761-6. doi: 10.1203/00006450-197807000-00004. Pediatr Res. 1978. PMID: 211480 No abstract available.
• Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.

  Fertel R, Weiss B. Fertel R, et al. Mol Pharmacol. 1976 Jul;12(4):678-87. Mol Pharmacol. 1976. PMID: 183099 No abstract available.
• [Phosphodiesterase of cyclic nucleotides].

  Etingof RN, Dumler IL. Etingof RN, et al. Ukr Biokhim Zh (1978). 1981 Mar-Apr;53(2):28-43. Ukr Biokhim Zh (1978). 1981. PMID: 6266102 Review. Russian.
• Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.

  Ariano MA, Appleman MM. Ariano MA, et al. Brain Res. 1979 Nov 16;177(2):301-9. doi: 10.1016/0006-8993(79)90781-9. Brain Res. 1979. PMID: 227534